Escherichia coli sequence type ST131 as an emerging fluoroquinolone-resistant uropathogen among renal transplant recipients

Antimicrob Agents Chemother. 2010 Jan;54(1):546-50. doi: 10.1128/AAC.01089-09. Epub 2009 Nov 16.

Abstract

Among 40 Escherichia coli urine isolates from renal transplant recipients (Galveston, TX, 2003 to 2005), sequence type ST131 (O25:H4) was highly prevalent (representing 35% of isolates overall and 60% of fluoroquinolone-resistant isolates), virulent appearing, antimicrobial resistant (but extended-spectrum-cephalosporin susceptible), and associated with black race. Pulsotypes were diverse; some were linked to other locales. ST131 emerged significantly during the study period. These findings suggest that E. coli ST131 may constitute an important new multidrug-resistant threat to renal transplant recipients.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adult
  • Aged
  • Anti-Bacterial Agents / pharmacology*
  • Bacteriophage phi X 174
  • Black People
  • DNA, Bacterial / genetics
  • Drug Resistance, Multiple, Bacterial / genetics*
  • Electrophoresis, Gel, Pulsed-Field
  • Escherichia coli / genetics*
  • Escherichia coli Infections / microbiology*
  • Female
  • Fluoroquinolones / pharmacology*
  • Humans
  • Kidney Transplantation*
  • Logistic Models
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged
  • Phylogeny
  • Reverse Transcriptase Polymerase Chain Reaction
  • Serotyping
  • Urinary Tract Infections / microbiology*
  • beta-Lactamases / metabolism

Substances

  • Anti-Bacterial Agents
  • DNA, Bacterial
  • Fluoroquinolones
  • beta-lactamase CTX-M-15
  • beta-Lactamases